Literature DB >> 20400899

Intensive insulin therapy improves insulin sensitivity and mitochondrial function in severely burned children.

Ricki Y Fram1, Melanie G Cree, Robert R Wolfe, Ronald P Mlcak, Ting Qian, David L Chinkes, David N Herndon.   

Abstract

OBJECTIVE: To institute intensive insulin therapy protocol in an acute pediatric burn unit and study the mechanisms underlying its benefits.
DESIGN: Prospective, randomized study.
SETTING: An acute pediatric burn unit in a tertiary teaching hospital. PATIENTS: Children, 4-18 yrs old, with total body surface area burned > or =40% and who arrived within 1 wk after injury were enrolled in the study.
INTERVENTIONS: Patients were randomized to one of two groups. Intensive insulin therapy maintained blood glucose levels between 80 and 110 mg/dL. Conventional insulin therapy maintained blood glucose < or =215 mg/dL.
MEASUREMENTS AND MAIN RESULTS: Twenty patients were included in the data analysis consisting of resting energy expenditure, whole body and liver insulin sensitivity, and skeletal muscle mitochondrial function. Studies were performed at 7 days postburn (pretreatment) and at 21 days postburn (posttreatment). Resting energy expenditure significantly increased posttreatment (1476 +/- 124 to 1925 +/- 291 kcal/m(2) x day; p = .02) in conventional insulin therapy as compared with a decline in intensive insulin therapy. Glucose infusion rate was identical between groups before treatment (6.0 +/- 0.8 conventional insulin therapy vs. 6.8 +/- 0.9 mg/kg x min intensive insulin therapy; p = .5). Intensive insulin therapy displayed a significantly higher glucose clamp infusion rate posttreatment (9.1 +/- 1.3 intensive insulin therapy versus 4.8 +/- 0.6 mg/kg x min conventional insulin therapy, p = .005). Suppression of hepatic glucose release was significantly greater in the intensive insulin therapy after treatment compared with conventional insulin therapy (5.0 +/- 0.9 vs. 2.5 +/- 0.6 mg/kg x min; intensive insulin therapy vs. conventional insulin therapy; p = .03). States 3 and 4 mitochondrial oxidation of palmitate significantly improved in intensive insulin therapy (0.9 +/- 0.1 to 1.7 +/- 0.1 microm O(2)/CS/mg protein/min for state 3, p = .004; and 0.7 +/- 0.1 to 1.3 +/- 0.1 microm O(2)/CS/mg protein/min for state 4, p < .002), whereas conventional insulin therapy remained at the same level of activity (0.9 +/- 0.1 to 0.8 +/- 0.1 microm O(2)/CS/mg protein/min for state 3, p = .4; 0.6 +/- 0.03 to 0.7 +/- 0.1 microm O(2)/CS/mg protein/min, p = .6).
CONCLUSION: Controlling blood glucose levels < or =120 mg/dL using an intensive insulin therapy protocol improves insulin sensitivity and mitochondrial oxidative capacity while decreasing resting energy expenditure in severely burned children.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20400899      PMCID: PMC3826175          DOI: 10.1097/CCM.0b013e3181de8b9e

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  49 in total

1.  Assessment of methods for improving tracer estimation of non-steady-state rate of appearance.

Authors:  A Gastaldelli; A R Coggan; R R Wolfe
Journal:  J Appl Physiol (1985)       Date:  1999-11

2.  Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing.

Authors:  Z Tang; J H Lee; R F Louie; G J Kost
Journal:  Arch Pathol Lab Med       Date:  2000-08       Impact factor: 5.534

Review 3.  Post burn muscle wasting and the effects of treatments.

Authors:  Clifford Pereira; Kevin Murphy; Marc Jeschke; David N Herndon
Journal:  Int J Biochem Cell Biol       Date:  2005-10       Impact factor: 5.085

4.  A comparison of blood glucose meters in Australia.

Authors:  Matthew Cohen; Erin Boyle; Carol Delaney; Jonathan Shaw
Journal:  Diabetes Res Clin Pract       Date:  2005-07-11       Impact factor: 5.602

5.  Intensive insulin treatment in critically ill trauma patients normalizes glucose by reducing endogenous glucose production.

Authors:  Anders Thorell; Olav Rooyackers; Peter Myrenfors; Mattias Soop; Jonas Nygren; Olle H Ljungqvist
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

6.  Insulin resistance, secretion and breakdown are increased 9 months following severe burn injury.

Authors:  Melanie G Cree; Ricki Y Fram; David Barr; David Chinkes; Robert R Wolfe; David N Herndon
Journal:  Burns       Date:  2008-07-30       Impact factor: 2.744

7.  Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.

Authors:  J R Gavin; J Roth; D M Neville; P de Meyts; D N Buell
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

8.  Comparison of point-of-care and laboratory glucose analysis in critically ill patients.

Authors:  Teresita Lacara; Caroline Domagtoy; Donna Lickliter; Kathy Quattrocchi; Lydia Snipes; Joánne Kuszaj; MaryClare Prasnikar
Journal:  Am J Crit Care       Date:  2007-07       Impact factor: 2.228

9.  Comparison of insulin sensitivity, clearance, and secretion estimates using euglycemic and hyperglycemic clamps in children.

Authors:  Gabriel I Uwaifo; S J Parikh; M Keil; J Elberg; J Chin; J A Yanovski
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

10.  Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity.

Authors:  A S Petrides; T Stanley; D E Matthews; C Vogt; A J Bush; H Lambeth
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

View more
  10 in total

1.  Management of burns in the elderly.

Authors:  G S Abu-Sittah; F M Chahine; H Janom
Journal:  Ann Burns Fire Disasters       Date:  2016-12-31

Review 2.  Anabolic and anticatabolic agents used in burn care: What is known and what is yet to be learned.

Authors:  Eduardo I Gus; Shahriar Shahrokhi; Marc G Jeschke
Journal:  Burns       Date:  2019-12-15       Impact factor: 2.744

3.  Timing of insulin therapy affects the inflammatory response in endotoxemic rats.

Authors:  Bo Zou; Qiyi Chen; Shaoqiu Tang; Tao Gao; Juanjuan Zhang; Fengchan Xi; Wenkui Yu
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

4.  Retinol binding protein: marker for insulin resistance and inflammation postburn?

Authors:  Robert Kraft; David N Herndon; Gabriela A Kulp; Gabriel A Mecott; Heiko Trentzsch; Marc G Jeschke
Journal:  JPEN J Parenter Enteral Nutr       Date:  2011-11       Impact factor: 4.016

Review 5.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

Review 6.  Alcohol Modulation of the Postburn Hepatic Response.

Authors:  Michael M Chen; Stewart R Carter; Brenda J Curtis; Eileen B O'Halloran; Richard L Gamelli; Elizabeth J Kovacs
Journal:  J Burn Care Res       Date:  2017 Jan/Feb       Impact factor: 1.845

Review 7.  Burns: an update on current pharmacotherapy.

Authors:  Yesenia Rojas; Celeste C Finnerty; Ravi S Radhakrishnan; David N Herndon
Journal:  Expert Opin Pharmacother       Date:  2012-11-02       Impact factor: 3.889

Review 8.  The impact of severe burns on skeletal muscle mitochondrial function.

Authors:  Craig Porter; David N Herndon; Labros S Sidossis; Elisabet Børsheim
Journal:  Burns       Date:  2013-05-10       Impact factor: 2.744

Review 9.  Cardiovascular Dysfunction Following Burn Injury: What We Have Learned from Rat and Mouse Models.

Authors:  Ashley N Guillory; Robert P Clayton; David N Herndon; Celeste C Finnerty
Journal:  Int J Mol Sci       Date:  2016-01-02       Impact factor: 5.923

10.  Relationship between hyperglycemia, hormone disturbances, and clinical evolution in severely hyperglycemic post surgery critically ill children: an observational study.

Authors:  Yolanda Ballestero; Jesús López-Herce; Rafael González; Maria José Solana; Jimena Del Castillo; Javier Urbano; Marta Botran; Ana García; Nieves López; Jose María Bellón
Journal:  BMC Endocr Disord       Date:  2014-03-14       Impact factor: 2.763

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.